CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
OPERATING ACTIVITIES:
Net income	$ 16,048	$ 15,224	$ 15,686
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,711	3,076	2,951
Write down of assets held for sale	0	0	475
Loss on sale of premises and equipment	18	(14)	474
Amortization of intangible assets	191	227	264
Provision for loan losses	640	2,625	2,735
Stock based compensation	960	854	680
Amortization of investment security discounts and premiums, net	1,142	793	671
Securities gains, available for sale	(699)	(1,592)	(640)
Originations of loans held for sale	(85,938)	(131,775)	(61,723)
Proceeds of loans held for sale	89,926	134,916	62,174
Gain on sale of loans	(2,474)	(4,148)	(1,754)
Net equity securities losses (gains)	37	(27)	(89)
Net securities losses (gains), trading	3	11	(19)
Proceeds from sales of trading securities	0	0	78
Purchases of trading securities	0	0	(74)
Security trades receivable	0	0	(6,626)
Security trades payable	(1,455)	(1,566)	0
Earnings on bank-owned life insurance	(916)	(653)	(574)
Decrease in deferred tax asset	(359)	309	814
Other, net	(2,912)	3,740	(1,453)
Net cash provided by operating activities	17,923	22,000	14,050
Investment debt securities available for sale:
Proceeds from sales	17,947	20,767	23,799
Proceeds from calls, maturities and repayments	20,997	23,292	6,845
Purchases	(46,499)	(54,043)	(40,180)
Proceeds from sales of equity securities	0	0	604
Net (increase) decrease in loans	(48,170)	10,269	24,010
Acquisition of premises and equipment	(1,137)	(2,668)	(2,706)
Proceeds from sale of premises and equipment	2	336	297
Proceeds from the sale of foreclosed assets	335	226	502
Purchase of bank-owned life insurance	(30)	(3,970)	(30)
Distribution of non-controlling interest	(25)	0	0
Proceeds from bank-owned life insurance death benefit	825	248	0
Investment in limited partnership	(1,070)	(3,347)	0
Proceeds from redemption of regulatory stock	3,143	3,561	13,934
Purchases of regulatory stock	(2,297)	(5,410)	(8,600)
Net cash (used for) provided by investing activities	(55,979)	(10,739)	18,475
FINANCING ACTIVITIES:
Net increase in interest-bearing deposits	81,869	55,827	90,170
Net increase in noninterest-bearing deposits	45,003	114,611	13,932
Proceeds from long-term borrowings	0	35,000	50,000
Repayment of long-term borrowings	(30,000)	(43,333)	(32,608)
Net increase (decrease) in short-term borrowings	503	324	(162,945)
Finance lease principal payments	(165)	(112)	(440)
Dividends paid	(9,041)	(9,020)	(8,876)
Distributions to non-controlling interest	(17)	(36)	0
Issuance of common stock	408	247	89
Net cash provided by (used for) financing activities	88,560	153,508	(50,678)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	50,504	164,769	(18,153)
CASH AND CASH EQUIVALENTS, BEGINNING	213,358	48,589	66,742
CASH AND CASH EQUIVALENTS, ENDING	263,862	213,358	48,589
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	9,157	14,974	15,438
Income taxes paid	4,236	2,945	3,567
Transfer of loans to foreclosed real estate	83	232	525
Transfer due to adoption of ASU 2016-01, equity securities fair value adjust, reclassification from AOCI to Retained Earnings, net of tax	0	0	537
Right of use lease assets obtained in exchange for lessee finance lease liabilities	2,653	0	6,026
Right of use lease assets obtained in exchange for lessee operations lease liabilities	$ 0	$ 0	$ 4,298